ArticleCancers2019
Diffusion-Weighted Imaging Can Differentiate between Malignant and Benign Pleural Diseases.
Article in Cancers, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 24 citations in OpenAlex.
- Diagnostic Challenges in Pleural Mesothelioma.Cancers · 2026Review
- Review
- 18F-FDG PET and combined diffusion weighted MRI features in pleural infection: A case report.Radiology case reports · 2025Article
- [Research Progress on Imaging Diagnosis of Non-small Cell Lung Cancer Which Invades Pleura or Chest Wall].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2025Review
- Malignant Pleural Effusion: Diagnosis and Treatment-Up-to-Date Perspective.Current oncology (Toronto, Ont.) · 2024Review
- A case of pleural lipoma evaluated with multi-imaging methods.Radiology case reports · 2024Article
- Pleural Neoplasms-What Could MRI Change?Cancers · 2023Review
- The Use of Chest Magnetic Resonance Imaging in Malignant Pleural Mesothelioma Diagnosis.Diagnostics (Basel, Switzerland) · 2022Review
- New Era for Malignant Pleural Mesothelioma: Updates on Therapeutic Options.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2022Review
- Early Response to Chemotherapy in Malignant Pleural Mesothelioma Evaluated Using Diffusion-Weighted Magnetic Resonance Imaging: Initial Observations.JTO clinical and research reports · 2021Article
- New Updates of the Imaging Role in Diagnosis, Staging, and Response Treatment of Malignant Pleural Mesothelioma.Cancers · 2021Review
- Tumor and tumorlike conditions of the pleura and juxtapleural region: review of imaging findings.Insights into imaging · 2021Review
- Review
- Diffusion-weighted whole-body imaging with background suppression (DWIBS) is effective and economical for detection of metastasis or recurrence of lung cancer.Thoracic cancer · 2021Article
- What Is the Role of Imaging in Cancers?Cancers · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 1 institution in 1 country.
Funding
Abstract
It is not clear whether magnetic resonance imaging (MRI) is useful for the assessment of pleural diseases. The aim of this study is to determine whether diffusion-weighted magnetic resonance imaging (DWI) can differentiate malignant pleural mesothelioma (MPM) from pleural dissemination of lung cancer, empyema or pleural effusion. The DWI was calibrated with the b value of 0 and 800 s/mm
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.